Bioaccess - Fast-Tracking First-in-Human Trials Email Formats

Bioaccess – Fast‑Tracking First‑in‑Human Trials was founded in 2010 and is headquartered in Miami, Florida. The MedTech CRO specializes in early feasibility studies and first‑in‑human (FIH) trials for medical devices, biopharma, radiopharmaceuticals, and nuclear medicine across Latin America, with expertise in INVIMA approval, patient recruitment, regulatory affairs, clinical research, and startup collaboration.

With a team of 10‑50 professionals, Bioaccess generates annual revenue between $10 million and $50 million. Leadership includes Senior Clinical Project Manager Leonardo Rueda; Director of Operations Bob Johnson; Chief Operating Officer Monica Mora; Clinical Project Manager Sergio Alvarado Garzon; Regulatory Manager Katherine Ruiz; Business Development Director Jesus Moreno; Marketing Director Sharick Rubio, among others.

Bioaccess - Fast-Tracking First-in-Human Trials uses 6 email formats across its organization. The most common pattern is lastName-firstName (e.g., doe-jane@bioaccessla.com), used in approximately 59% of work addresses.

Bioaccess - Fast-Tracking First-in-Human Trials currently employs over 10-50 people from United States, Colombia, Brazil, Philippines, with a head office in Miami, Florida, US.